Comparison of Multiple Oral and/or Intravenous Anti-platelet Strategies in Patients With ST-segment Elevation Myocardial Infarction Undergoing Primary PCI.
Phase of Trial: Phase III
Latest Information Update: 09 Oct 2012
At a glance
- Drugs Prasugrel (Primary) ; Tirofiban
- Indications Myocardial infarction; Thromboembolism
- Focus Pharmacodynamics
- Acronyms FABOLUS-PRO
- 23 Aug 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Apr 2011 New trial record